Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Plasma protein solutions and synthetic plasma substitutes have an established role in therapy in many areas of clinical medicine. Although there have been many advances in the field of plasma volume expanders, an effective, stable, readily available and economical solution, free from side effects remains elusive. In particular, all plasma volume expanders may be associated with a small, but significant incidence of side effects. Allergic and anaphylactoid reactions are the most feared, but questions about prolonged storage and effects on haemostasis and renal function should be considered. Plasma protein fraction may be associated with hypotension, probably due to kinin activation. In the fully conscious patient, features of vasodilatation including flushing, fullness in the head, nasal stuffiness, may also be noted. There have also been reports of true anaphylactic type reactions occurring in atopic subjects after the infusion of small amounts of plasma protein solution. Modified fluid gelatins are well known to release histamine when infused rapidly. The reactions are usually confined to the skin and present clinically as pruritis, urticaria or flushing. There are also reports of anaphylactic reactions not related to dosage which are probably immune in origin. The dextrans are well recognised to cause such anaphylactoid reactions. Accepting that anaphylactoid and anaphylactic reactions may occur in association with plasma volume expanders, anticipation, diagnosis and rapid institution of therapy determine the outcome of these reactions.
Plasma protein solutions and synthetic plasma substitutes have an established role in therapy in many areas of clinical medicine. Although there have been many advances in the field of plasma volume expanders, an effective, stable, readily available and economical solution, free from side effects remains elusive. In particular, all plasma volume expanders may be associated with a small, but significant incidence of side effects. Allergic and anaphylactoid reactions are the most feared, but questions about prolonged storage and effects on haemostasis and renal function should be considered. Plasma protein fraction may be associated with hypotension, probably due to kinin activation. In the fully conscious patient, features of vasodilatation including flushing, fullness in the head, nasal stuffiness, may also be noted. There have also been reports of true anaphylactic type reactions occurring in atopic subjects after the infusion of small amounts of plasma protein solution. Modified fluid gelatins are well known to release histamine when infused rapidly. The reactions are usually confined to the skin and present clinically as pruritis, urticaria or flushing. There are also reports of anaphylactic reactions not related to dosage which are probably immune in origin. The dextrans are well recognised to cause such anaphylactoid reactions. Accepting that anaphylactoid and anaphylactic reactions may occur in association with plasma volume expanders, anticipation, diagnosis and rapid institution of therapy determine the outcome of these reactions.
Severe anaphylactoid reactions during anaesthesia in 116 patients are described. The majority of patients who reacted to induction agents had previous exposure to the drug, while the majority of patients who reacted to muscle relaxants had not. There was a statistically significant increased incidence of allergy, atopy, asthma and previous reactions in patients who had reactions compared with a control group undergoing uneventful anaesthesia. There was no correlation between abnormalities in immunoglobulins or resting complement levels and a history of allergy or atopy. Antihistamines, steroids and bronchodilators alone did not prevent reactions and three patients reacted to test doses with Althesin. Reactions usually occurred during induction of anaesthesia, but may occur at any time in the perioperative period. No one drug produced reactions that differed in severity or clinical features from any other drug. Clinical features included skin changes, oedema, cardiovascular collapse, bronchospasm, gastrointestinal symptoms, prolonged unconsciousness, convulsions and pulmonary oedema. Four patients died.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.